drugset / Trial / NCT01302964
Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will determine the effectiveness of mirtazapine in reducing anxiety in children with autistic disorder, Asperger's disorder and Pervasive Developmental Disorder.
Timeline
- Start
- 2010-08
- Primary completion
- 2017-10-10
- Completion
- 2017-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirtazapine | Other / unclassified | 45 mg | — |